VIRAL INFECTIONS: CHARACTERISTICS OF HEPATITIS VIRUSES AND LABORATORY DIAGNOSIS OF THE DISEASES THEY CAUSE
Keywords:
hepatitis viruses, HAV, HBV, HCV, HDV, HEV, laboratory diagnosis, serology, PCR, viral hepatitisAbstract
Background: Viral hepatitis, primarily caused by hepatotropic viruses (HAV, HBV, HCV, HDV, and HEV), represents a major global public health problem, leading to acute and chronic liver disease, cirrhosis, and hepatocellular carcinoma (HCC). Objective: To analyze the key virological characteristics of the five main hepatitis viruses and to describe the contemporary laboratory diagnostic methods used for their identification and clinical management. Methods: A narrative review was conducted based on peer-reviewed literature and international guidelines from databases such as PubMed, Scopus, and WHO reports. Results: Each hepatitis virus exhibits distinct structural, genomic, and transmission characteristics. HAV and HEV cause acute, self-limiting enterically-transmitted infections. HBV, HCV, and HDV (a defective virus requiring HBV) cause parenterally transmitted chronic infections. Laboratory diagnosis relies on a combination of serological assays detecting specific viral antigens and antibodies (e.g., HBsAg, anti-HCV) and molecular methods (PCR, qPCR) for viral nucleic acid detection, quantification, and genotyping. Conclusion: Accurate differential diagnosis of viral hepatitis is critical for appropriate patient management. A stepwise laboratory algorithm utilizing serology for initial screening followed by molecular confirmation and monitoring is the cornerstone of modern diagnostics.
References
1. World Health Organization. Global hepatitis report 2024. Geneva: WHO; 2024.
2. Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599.
3. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C 2020. J Hepatol. 2020;73(5):1170-1218.
4. Negro F. Hepatitis D virus: an update. Liver Int. 2019;39(Suppl 1):9-19.
5. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis. 2008;8(11):698-709.
6. Pawlotsky JM. Use of diagnostic tests in clinical practice. Clin Liver Dis. 2019;23(3):437-452.
7. Chevaliez S, Pawlotsky JM. Hepatitis C virus serologic and molecular tests in clinical practice. Curr Hepat Rep. 2019;18(2):89-97.
8. Franco E, Meleleo C, Serino L, Sorbara D, Zaratti L. Hepatitis A: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):68-73.
9. Kamili S, Drobeniuc J. Molecular detection of hepatitis E virus. Methods Mol Biol. 2020;2106:73-85.
10. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat. 2004;11(2):97-107.